Therapeutic Drug Monitoring of Aminoglycosides in Neonates

被引：0
|
作者：
Matthijs de Hoog
John N. van den Anker
机构：
[1] Sophia Children’s Hospital,Intensive Care Unit, Department of Pediatrics, Erasmus Medical Center
[2] Children’s National Medical Center/George Washington University School of Medicine and Health Sciences,Departments of Pediatrics, Pharmacology and Physiology
来源：
Clinical Pharmacokinetics | 2009年 / 48卷
关键词：
Hearing Loss; Aminoglycosides; Predictive Performance; Therapeutic Drug Monitoring; Pharmacokinetic Behaviour;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：343 / 344
页数：1
相关论文
共 50 条
  • [31] THE EFFECT OF THERAPEUTIC DRUG MONITORING IN PATIENTS COMPLIANCE: AN IMPROVEMENT IN DRUG EFFICACY AND CORRESPONDING REDUCTION IN TOXICITY USING AMINOGLYCOSIDES
    Okoro, K., I
    VALUE IN HEALTH, 2016, 19 (07) : A519 - A520
  • [32] Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring
    Croes, Sander
    Koop, Arjen H.
    van Gils, Stephen A.
    Neef, Cees
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 45 (1-2) : 90 - 100
  • [33] Extended-interval dosing of tobramycin in neonates: Implications for therapeutic drug monitoring
    de Hoog, M
    Mouton, JW
    Schoemaker, RC
    Verduin, CM
    van den Anker, JN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (05) : 349 - 358
  • [34] Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring
    De Waele, J. J.
    De Neve, N.
    MINERVA ANESTESIOLOGICA, 2014, 80 (10) : 1135 - 1142
  • [35] Group B streptococcus and high level resistance to aminoglycosides: therapeutic implications for neonates
    Mariani-Kurkdjian, P
    Benayoun, E
    Bingen, E
    Aujard, Y
    ARCHIVES DE PEDIATRIE, 2003, 10 (08): : 736 - 737
  • [36] BENEFIT OF A COMPUTERIZED PROGRAM FOR AMINOGLYCOSIDES DRUG-MONITORING
    BROUARD, A
    HUBERT, I
    BAUD, F
    CLAVIER, N
    GALLIOT, M
    BISMUTH, C
    TERRIER, JL
    THERAPIE, 1989, 44 (05): : 331 - 336
  • [37] Innovation in microsampling for therapeutic drug monitoring of gentamicin in neonates: a proof-of-concept study
    Parker, Suzanne L.
    Irwin, Adam D.
    Hosking, Francine
    August, Deanne
    Schoenmaker, Brittany
    Pandey, Saurabh
    Wallis, Steven C.
    Lipman, Jeffrey
    Roberts, Jason A.
    Davies, Mark W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (02)
  • [38] Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis
    van Altena, R.
    Dijkstra, J. A.
    van der Meer, M. E.
    Howard, J. F. Borjas
    Kosterink, J. G. W.
    van Soolingen, D.
    van der Werf, T. S.
    Alffenaar, J. W. C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (03)
  • [39] Assays for therapeutic monitoring and pharmacokinetic investigations of aminoglycosides: Quality aspects
    White, LO
    THERAPEUTIC DRUG MONITORING, 1998, 20 (05) : 464 - 468
  • [40] Optimal Therapeutic Drug Monitoring Strategy for IV Aminoglycosides and IV Vancomycin in People with Cystic Fibrosis: A Systematic Review
    Jiang, Jessie
    Giunio-Zorkin, Nicole
    Su, Victoria
    Dagenais, Renee
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2023, 76 (04): : 317 - 323
12345